Hualan Biological Engineering
002007.SZ
#3437
Rank
HK$31.10 B
Marketcap
HK$17.02
Share price
0.32%
Change (1 day)
-4.86%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): HK$1.54 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are HK$0.63 Billion. In 2024 the company made an earning of HK$1.46 Billion a decrease over its 2023 earnings that were of HK$2.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$1.54 B5.83%
2024 HK$1.46 B-36.03%
2023 HK$2.28 B39.14%
2022 HK$1.64 B-19.27%
2021 HK$2.03 B-17.84%
2020 HK$2.47 B37.54%
2019 HK$1.79 B11.56%
2018 HK$1.61 B50.74%
2017 HK$1.06 B1.03%
2016 HK$1.05 B23.54%
2015 HK$0.85 B8.4%
2014 HK$0.79 B10.91%
2013 HK$0.71 B54.55%
2012 HK$0.46 B-17.1%
2011 HK$0.55 B-41.28%
2010 HK$0.94 B6.13%
2009 HK$0.89 B261.35%
2008 HK$0.24 B85.72%
2007 HK$0.13 B49.33%
2006 HK$89.09 M56.91%
2005 HK$56.77 M34.29%
2004 HK$42.28 M